Understanding issues around physician education and uptakeHost: Jonathan Underhill, Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICEJames Kent, Regional medicine procurement specialist East of England, NHS EnglandTim McCarthy, Deputy Chief Pharmacist., The Royal Marsden NHS Foundation Trust
WHO Guidelines on Global reference productIngrid Schwarzenberger, Head Global Regulatory Affairs, Sandoz BiopharmaceuticalsSuzette Kox, Senior Director International - Biosimilar Medicines Group, Medicines for EuropeMareike Ostertag, Director Science & Regulatory policy, Novartis
Tackling IP and Legal challengesStacie Ropka, Partner, Axinn, Veltrop & Harkrider LLP
Working with multi-cultural, global virtual teams to develop biosimilar products – Challenges and solutionsShantreddy Soogareddy, Associate Director External R&D, Dr. Reddy's Laboratories SA.
Characterisation and analytics of products on the marketTudor Arvinte, Owner, Therapeomic Inc.
Market accessAdam Levysohn, Sr Director Market Access Biosimilar, Biogen
How to deal with competition and set yourself apart from other biosimilar companiesIf you are interested in being involved, please contact Derek Cavanagh at firstname.lastname@example.org or +44 207 092 1297
InterchangeabilityMathias Flume, Head of Drug Department, KVWL
Challenging current FDA guidelines for BiosimilarsSarfaraz Niazi, Chairman, Professor, Karyo Biologics/University of Illinois